Price: $0.3400
$0.03
9.677%
|
Day's High:
| $0.4297
| Week Perf:
| -15 %
|
Day's Low: |
$ 0.34 |
30 Day Perf: |
30.27 % |
Volume (M): |
2 |
52 Wk High: |
$ 0.95 |
Volume (M$): |
$ 1 |
52 Wk Avg: |
$0.50 |
Open: |
$0.35 |
52 Wk Low: |
$0.19 |
|
|
Market Capitalization (Millions $) |
2 |
Shares
Outstanding (Millions) |
7 |
Employees |
62 |
Revenues (TTM) (Millions $) |
23 |
Net Income (TTM) (Millions $) |
-5 |
Cash Flow (TTM) (Millions $) |
0 |
Capital Exp. (TTM) (Millions $) |
0 |
Cyanotech Corp
We are a world leader in the production of high value natural products derived
from microalgae. Incorporated in 1983, we are guided by the principle of providing
beneficial, quality microalgal products for health and human nutrition in a
sustainable, reliable and environmentally sensitive operation. We are GMP (Good
Manufacturing Practices) certified by the Natural Products Association™,
reinforcing our commitment to quality in our products, quality in our relationships
(with our customers, suppliers, employees and the communities we live in), and
quality of the environment in which we work. Our products include:
Hawaiian BioAstin® natural astaxanthin - a powerful dietary antioxidant
shown to support and maintain the body’s natural inflammatory response,
to enhance skin, and to support eye and joint health. It has expanding applications
as a human nutraceutical and functional food ingredient; and
Hawaiian Spirulina Pacifica® - a nutrient-rich dietary supplement used for
extra energy, a strengthened immune system, cardiovascular benefits and as a
source of antioxidant carotenoids
Microalgae are a diverse group of microscopic plants that have a wide range
of physiological and biochemical characteristics and contain, among other things,
high levels of natural protein, amino acids, vitamins, pigments and enzymes.
Microalgae have the following properties that make commercial production attractive:
(1) microalgae grow much faster than land grown plants, often up to 100 times
faster; (2) microalgae have uniform cell structures with no bark, stems, branches
or leaves, permitting easier extraction of products and higher utilization of
the microalgae cells; and (3) the cellular uniformity of microalgae makes it
practical to control the growing environment in order to optimize a particular
cell characteristic. Efficient and effective cultivation of microalgae requires
consistent light, warm temperatures, low rainfall and proper chemical balance
in a very nutrient-rich environment, free of environmental contaminants and
unwanted organisms. This is a challenge that has motivated us to design, develop
and implement proprietary production and harvesting technologies, systems and
processes in order to commercially produce human nutritional products derived
from microalgae.
Our production of these products at the 90-acre facility on the Kona Coast of
the island of Hawaii provides several benefits. We selected the Keahole Point
location in order to take advantage of relatively consistent warm temperatures,
sunshine and low levels of rainfall needed for optimal cultivation of microalgae.
This location also offers us access to cold deep ocean water, drawn from an
offshore depth of 2,000 feet, which we use in our Ocean-Chill Drying system
to eliminate the oxidative damage caused by standard drying techniques and as
a source of trace nutrients for microalgal cultures. The area is also designated
a Biosecure Zone, with tight control of organisms allowed into the area and
free of genetically modified organisms (GMO’s). We believe that our technology,
systems, processes and favorable growing location generally permit year-round
harvest of our microalgal products in a cost-effective manner.
Our Business
We operate entirely in one operating segment, the cultivation and production
of microalgae into high-value, high-quality natural health and nutrition products.
We cultivate, on a large-scale basis, two microalgal species from which our
two major product lines, natural astaxanthin products and spirulina products,
are derived. We record revenue and cost of sales information by product category,
but do not record operating expenses by such product category.
Company Address: 73-4460 Queen Kaahumanu Hwy. #102 Kailua-Kona 96740 HI
Company Phone Number: 326-1353 Stock Exchange / Ticker: CYAN
|
|
|
|
|
Stock Performances by Major Competitors |
|
|
Cyanotech Corp
Cyanotech Corp is a company that specializes in producing high-quality nutritional supplements derived from microalgae, specifically spirulina and astaxanthin. The company has been in operation for over 35 years and has established itself as a leader in the natural products industry. However, the company has faced challenges in recent years, as evidenced by its financial performance in the January to March 31 2024 fiscal period. During this period, Cyanotech Corp reported a loss per share of $-0.29, an increase from $-0.23 in the previous year and $-0.16 in the prior quarter. The company also experienced a significant increase in revenue, with a growth of 71.607% to $7.68 million compared to $4.47 million in the same quarter a year prior. Sequentially, revenue surged by 65.111% from $4.65 million.
|
Cyanotech Corp
The stock market can be a volatile and unpredictable place, with companies constantly reporting their financial results and investors trying to make sense of it all. One such company that recently reported its fiscal period results is Cyanotech Corp, a producer of natural products derived from microalgae. In the most recent fiscal period, Cyanotech reported a deficit per share of $-0.16, compared to $-0.10 in the same period a year prior. This represents a significant increase in losses for the company. Additionally, the revenue for the period declined by a staggering -19.344%, dropping from $5.76 million to $4.65 million. Sequentially, revenue fell even further by -23.637% from $6.09 million. These numbers reflect a challenging time for Cyanotech, as they struggle to maintain profitability and grow their top line.
|
Cyanotech Corp
Cyanotech Corp, a leading biotechnology company specializing in microalgae-based health and nutrition products, recently released its financial results for the most recent fiscal period. While the company has experienced a decrease in losses per share and a significant increase in revenue, there are mixed opinions about the future prospects of the company given its market and stock performance. Financial Performance: In the most recent fiscal period, Cyanotech Corp reported a decrease in its loss per share from $-0.15 to $-0.13, indicating an improvement compared to the previous year. Furthermore, the company's earnings per share (EPS) demonstrated substantial growth, with an increase from $-0.22 to $-0.13 per share in the prior reporting period.
|
Per Share |
Current |
Earnings (TTM) |
-0.78 $ |
Revenues (TTM) |
3.32 $
|
Cash Flow (TTM) |
- |
Cash |
0.11 $
|
Book Value |
1.38 $
|
Dividend (TTM) |
0 $ |
|
Per Share |
|
Earnings (TTM) |
-0.78 $
|
Revenues (TTM) |
3.32 $ |
Cash Flow (TTM) |
- |
Cash |
0.11 $
|
Book Value |
1.38 $ |
Dividend (TTM) |
0 $ |
|
|
|
Packaged Astaxanthin |
|
56.93 % |
of total Revenue |
Packaged Spirulina |
|
19.84 % |
of total Revenue |
Packaged Products |
|
76.77 % |
of total Revenue |
Bulk Astaxanthin |
|
11.53 % |
of total Revenue |
Bulk Spirulina |
|
12.96 % |
of total Revenue |
Bulk Products |
|
24.49 % |
of total Revenue |
Contract Extraction and R D Services |
|
5.42 % |
of total Revenue |
|
|